# Fred R. Hirsch

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/fred-r-hirsch/

## Facts

| Field | Value |
| --- | --- |
| Citations | 52,799 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 102 |
| i10-index | 325 |
| Last Known Institution | Mount Sinai Health System |
| OpenAlex ID | https://openalex.org/A5071851332 |
| ORCID iD | https://orcid.org/0000-0002-6885-1894 |
| Works | 763 |

## Researcher papers

Showing 12 of 17.

- [International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma](https://scholariq.org/papers/international-association-for-the-study-of-lung-cancer-american-thoracic-society/)
- [Lung cancer: current therapies and new targeted treatments](https://scholariq.org/papers/lung-cancer-current-therapies-and-new-targeted-treatments/)
- [PD-L1 as a biomarker of response to immune-checkpoint inhibitors](https://scholariq.org/papers/pd-l1-as-a-biomarker-of-response-to-immune-checkpoint-inhibitors/)
- [Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology](https://scholariq.org/papers/updated-molecular-testing-guideline-for-the-selection-of-lung-cancer-patients/)
- [PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 Project](https://scholariq.org/papers/pd-l1-immunohistochemistry-comparability-study-in-real-life-clinical-samples/)
- [Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non–Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors](https://scholariq.org/papers/assessing-tumor-infiltrating-lymphocytes-in-solid-tumors-a-practical-review-for/)
- [A Prospective, Multi-institutional, Pathologist-Based Assessment of 4 Immunohistochemistry Assays for PD-L1 Expression in Non–Small Cell Lung Cancer](https://scholariq.org/papers/a-prospective-multi-institutional-pathologist-based-assessment-of-4/)
- [Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC](https://scholariq.org/papers/liquid-biopsy-for-advanced-non-small-cell-lung-cancer-nsclc-a-statement-paper/)
- [A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee](https://scholariq.org/papers/a-grading-system-for-invasive-pulmonary-adenocarcinoma-a-proposal-from-the/)
- [IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy](https://scholariq.org/papers/iaslc-multidisciplinary-recommendations-for-pathologic-assessment-of-lung-cancer/)
- [PD-L1 Testing for Lung Cancer in 2019: Perspective From the IASLC Pathology Committee](https://scholariq.org/papers/pd-l1-testing-for-lung-cancer-in-2019-perspective-from-the-iaslc-pathology/)
- [Low-Dose Apatinib Optimizes Tumor Microenvironment and Potentiates Antitumor Effect of PD-1/PD-L1 Blockade in Lung Cancer](https://scholariq.org/papers/low-dose-apatinib-optimizes-tumor-microenvironment-and-potentiates-antitumor/)

## Researcher topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)

## Researcher university

- [Mount Sinai Health System](https://scholariq.org/institutions/mount-sinai-health-system/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.